Skip to main content
Top
Published in: Clinical and Experimental Nephrology 2/2011

01-04-2011 | Original Article

A simple model for predicting incidence of chronic kidney disease in HIV-infected patients

Authors: Minoru Ando, Naoki Yanagisawa, Atsushi Ajisawa, Ken Tsuchiya, Kosaku Nitta

Published in: Clinical and Experimental Nephrology | Issue 2/2011

Login to get access

Abstract

Background

Human immunodeficiency virus (HIV)-infected individuals have concurrent risk factors for chronic kidney disease (CKD), but there are no prediction models to quantify the effect of multiple factors on the development of incident CKD.

Methods

A 1-year prognostic model was developed using prospective data between January 2008 and March 2009, from a derivation cohort of 623 patients with an estimated glomerular filtration rate (eGFR) exceeding 60 ml/min/1.73 m2 at baseline. Incident CKD was defined as both an eGFR falling below 60 ml/min/1.73 m2 and a decrease in eGFR of at least 25% during the period. Continuous variables were divided into categories using the mean value of the whole cohort. Multivariate logistic regression was used to determine baseline categories associated with incident CKD. The model was tested with prospective data between April 2009 and March 2010, from a validation cohort of 534 patients exceeding 60 ml/min/1.73 m2 at baseline, consisting of part of the derivation cohort and newly enrolled patients. The discriminative ability was evaluated using the area under the receiver operating characteristic (AROC) curve.

Results

Eighteen subjects developed incident CKD (2.9%). In a multivariate logistic regression analysis of the derivation cohort, 5 variables (age, CD4 cell count, diabetes, proteinuria, and eGFR at baseline) were independently associated with the incidence of CKD. The AROC curve was 0.841 (95% CI 0.799–0.894) in the validation cohort.

Conclusion

This prediction model may be a useful tool for identifying HIV-infected individuals with a high likelihood of new-onset CKD.
Literature
1.
go back to reference Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol. 2004;15:2477–85.PubMedCrossRef Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol. 2004;15:2477–85.PubMedCrossRef
2.
go back to reference Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005;16:2412–20.PubMedCrossRef Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005;16:2412–20.PubMedCrossRef
3.
go back to reference Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435–43.PubMedCrossRef Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435–43.PubMedCrossRef
4.
go back to reference Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47:1449–57.PubMedCrossRef Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47:1449–57.PubMedCrossRef
5.
6.
go back to reference Kalaitzidis RG, Bakiris GL. Prehypertension: is it relevant for nephrologists? Kidney Int. 2010;77(3):194–200.PubMedCrossRef Kalaitzidis RG, Bakiris GL. Prehypertension: is it relevant for nephrologists? Kidney Int. 2010;77(3):194–200.PubMedCrossRef
7.
go back to reference Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting-enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.PubMed Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting-enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.PubMed
8.
go back to reference Mogensen CE. Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Res Clin Pract. 2008;82(Suppl 1):S2–9.PubMedCrossRef Mogensen CE. Twelve shifting paradigms in diabetic renal disease and hypertension. Diabetes Res Clin Pract. 2008;82(Suppl 1):S2–9.PubMedCrossRef
9.
go back to reference Kasiske BL, Lakatuab JD, Ma JZ, Louise TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998;31:954–61.PubMedCrossRef Kasiske BL, Lakatuab JD, Ma JZ, Louise TA. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis. 1998;31:954–61.PubMedCrossRef
10.
go back to reference Gansevoort RT, Bakker SJL, de Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17:1218–20.PubMedCrossRef Gansevoort RT, Bakker SJL, de Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17:1218–20.PubMedCrossRef
11.
go back to reference Taai MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006;70:1694–705.CrossRef Taai MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006;70:1694–705.CrossRef
12.
go back to reference Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21:1119–27.PubMedCrossRef Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21:1119–27.PubMedCrossRef
13.
go back to reference Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007;21:2101–3.PubMedCrossRef Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007;21:2101–3.PubMedCrossRef
14.
go back to reference Cheung CY, Wong KM, Lee MP, Liu YL, Kwok H, Chung R, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007;22:3186–90.PubMedCrossRef Cheung CY, Wong KM, Lee MP, Liu YL, Kwok H, Chung R, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007;22:3186–90.PubMedCrossRef
15.
go back to reference Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335:89–94.PubMedCrossRef Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335:89–94.PubMedCrossRef
16.
go back to reference Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM Study. Arch Intern Med. 2007;167:2213–9.PubMedCrossRef Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, Shlipak MG. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM Study. Arch Intern Med. 2007;167:2213–9.PubMedCrossRef
17.
go back to reference Daugas E, Rougier JP, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int. 2005;67:393–403.PubMedCrossRef Daugas E, Rougier JP, Hill G. HAART-related nephropathies in HIV-infected patients. Kidney Int. 2005;67:393–403.PubMedCrossRef
18.
go back to reference Izzedine H, Harris M, Perazella M. The nephrotoxic effect of HAART. Nat Rev Nephrol. 2009;5:563–73.PubMedCrossRef Izzedine H, Harris M, Perazella M. The nephrotoxic effect of HAART. Nat Rev Nephrol. 2009;5:563–73.PubMedCrossRef
19.
go back to reference Côté HCF, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, et al. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antivir Ther. 2006;11:79–86.PubMed Côté HCF, Magil AB, Harris M, Scarth BJ, Gadawski I, Wang N, et al. Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy. Antivir Ther. 2006;11:79–86.PubMed
20.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef
21.
go back to reference Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting: the ARIC study. Am J Epidemiol. 2009;170:414–24.PubMedCrossRef Bash LD, Coresh J, Kottgen A, Parekh RS, Fulop T, Wang Y, Astor BC. Defining incident chronic kidney disease in the research setting: the ARIC study. Am J Epidemiol. 2009;170:414–24.PubMedCrossRef
22.
go back to reference Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood. 2001;97:915–21.PubMedCrossRef Ando M, Iwamoto Y, Suda A, Tsuchiya K, Nihei H. New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood. 2001;97:915–21.PubMedCrossRef
23.
go back to reference Nakamura Y, Shibuya A, Suzuki H, Ando M. Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients. Nippon Jinzo Gakkai Shi. 2008;50:499–505.PubMed Nakamura Y, Shibuya A, Suzuki H, Ando M. Prevalence of chronic kidney disease (CKD) and significant contributors to CKD in HIV-infected patients. Nippon Jinzo Gakkai Shi. 2008;50:499–505.PubMed
24.
go back to reference Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374–81.PubMedCrossRef Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med. 2007;167:374–81.PubMedCrossRef
25.
go back to reference Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–7.PubMedCrossRef Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr. 2007;96:644–7.PubMedCrossRef
26.
go back to reference Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043–51.PubMedCrossRef Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043–51.PubMedCrossRef
27.
go back to reference Kshirsagar AV, Bang H, Bomback A, et al. A simple algorithm to predict incident kidney disease. Arch Intern Med. 2008;168:2466–73.PubMedCrossRef Kshirsagar AV, Bang H, Bomback A, et al. A simple algorithm to predict incident kidney disease. Arch Intern Med. 2008;168:2466–73.PubMedCrossRef
28.
go back to reference Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract. 2009;111:c39–48.PubMedCrossRef Barraclough K, Er L, Ng F, Harris M, Montaner J, Levin A. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract. 2009;111:c39–48.PubMedCrossRef
Metadata
Title
A simple model for predicting incidence of chronic kidney disease in HIV-infected patients
Authors
Minoru Ando
Naoki Yanagisawa
Atsushi Ajisawa
Ken Tsuchiya
Kosaku Nitta
Publication date
01-04-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 2/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0393-x

Other articles of this Issue 2/2011

Clinical and Experimental Nephrology 2/2011 Go to the issue